GNS Collaborated with Servier to Advance Drug Discovery and Clinical Development for Multiple Myeloma Using AI


The companies collaborated to advance drug discovery, translational, and clinical development efforts for MM by using AI and biosimulation along with other digital initiatives
The collaboration will utilize GNS’ Digital Twin and unique causal AI models to accelerate the research and early development to address the need of patients with MM
GNS’ MM Digital Twin has been developed using the rich clinico-genomic data from the MMRF (CoMMpass) study to develop a precise, quantifiable, transparent representation of complex biological mechanisms, uncovering new disease circuitry in humans

Ref: PRNewswire | Image: GNS